Manitoba Medical Service Foundation   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Winnipeg Manitoba Canada (1971)

Organization Overview

First Clinical Trial
2003
NCT00141986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Manitoba Medical Service Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

tadalafil (cialis) (1 trial)

Drugs in Phase 3 Trials (1)

resveratrol (1 trial)

Drugs in Phase 2 Trials (1)

testosterone (delatestryl) (1 trial)

Drugs in Phase 1 Trials (3)

boric acid (1 trial)

fluconazole (diflucan) (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (1)

omega-3 fatty acids (Omacor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Fatigue (Phase 2)

Hypotension (Phase 4)

Multiple Sclerosis (Phase 2)

Sclerosis (Phase 2)

Spinal Cord Injuries (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7